Home › Funds › Willis Investment Counsel › JNJ

Willis Investment Counsel position in JNJ

JOHNSON & JOHNSON · Health Care

Willis Investment Counsel reported holding 260,759 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$69.0M, representing 3.51% of its reported portfolio and ranking #2 among its reported holdings. Willis Investment Counsel has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)260.76K sh
Reported value held$69.03M
Portfolio Weight3.51%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Willis Investment Counsel's JNJ position evolved

Willis Investment Counsel first disclosed a stake in JNJ in Q3 2023 at 295,341 shares (US$46.0M). The position peaked in Q2 2026 at 309,486 shares, worth US$78.6M. Across 13 filings, Willis Investment Counsel increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 260,759 shares valued at US$69.0M — a reduction of -48,727 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 295.34K $46.00M New
Q4 2023 295.64K $46.34M Hold
Q1 2024 295.74K $46.78M Hold
Q2 2024 308.03K $45.02M Add
Q3 2024 308.89K $50.06M Hold
Q4 2024 331.98K $48.01M Add
Q1 2025 332.09K $55.07M Hold
Q2 2025 360.13K $55.01M Add
Q3 2025 360.13K $66.78M Hold
Q4 2025 365.40K $75.62M Add
Q1 2026 289.42K $70.75M Reduce
Q2 2026 309.49K $78.60M Add
Q3 2026 260.76K $69.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Willis Investment Counsel held JNJ?

Willis Investment Counsel has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Willis Investment Counsel's current position in JNJ?

As of Q3 2026, Willis Investment Counsel holds 260.76K shares of JNJ (JOHNSON & JOHNSON), valued at $69.03M, representing 3.51% of its reported portfolio and ranking #2.

Has Willis Investment Counsel been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Willis Investment Counsel reduced its position in JNJ. The position peaked in Q2 2026 at 309.49K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.